Bruno Claude Daniel Fauvet
+41 21 693 38 56
EPFL
>
SB
>
IPHYS
>
LBS
Web site: Web site: https://lbs.epfl.ch/
Publications
Infoscience publications
LMNN publications
The H50Q Mutation Enhances alpha-Synuclein Aggregation, Secretion, and Toxicity, in Journal Of Biological Chemistry, vol. 289, num. 32, p. 21856-21876, 2014.
. Protein semisynthesis and total synthesis approaches to elucidate the role of Alpha-Synuclein post-translational modifications. EPFL, Lausanne, 2014.
c-Abl phosphorylates ?-synuclein and regulates its degradation: implication for ?-synuclein clearance and contribution to the pathogenesis of Parkinson's disease, in Human molecular genetics, vol. 23, num. 11, p. 2858-79, 2014.
Alpha-synuclein Post-translational Modifications as Potential Biomarkers for Parkinson Disease and Other Synucleinopathies, in Molecular & Cellular Proteomics, vol. 12, num. 12, p. 3543-3558, 2013.
Synthetic polyubiquitinated ?-Synuclein reveals important insights into the roles of the ubiquitin chain in regulating its pathophysiology, in Proceedings of the National Academy of Sciences of the United States of America, vol. 110, num. 44, p. 17726-31, 2013.
One-pot total chemical synthesis of human ?-synuclein, in Chemical communications (Cambridge, England), vol. 49, num. 81, p. 9254-6, 2013.
One-pot total chemical synthesis of human ?-synuclein, in Chemical communications (Cambridge, England), vol. 49, num. 81, p. 9254-6, 2013.
Characterization of Molecular Determinants of the Conformational Stability of Macrophage Migration Inhibitory Factor: Leucine 46 Hydrophobic Pocket, in PLoS ONE, vol. 7, num. 9, p. e45024, 2012.
Characterization of semisynthetic and naturally N?-acetylated ?-synuclein in vitro and in intact cells: implications for aggregation and cellular properties of ?-synuclein, in The Journal of biological chemistry, vol. 287, num. 34, p. 28243-62, 2012.
?-Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer, in The Journal of biological chemistry, vol. 287, num. 19, p. 15345-64, 2012.
Elucidating the role of C-terminal post-translational modifications using protein semisynthesis strategies: ?-synuclein phosphorylation at tyrosine 125, in Journal of the American Chemical Society, vol. 134, num. 11, p. 5196-210, 2012.
Chemical strategies for controlling protein folding and elucidating the molecular mechanisms of amyloid formation and toxicity, in Journal of molecular biology, vol. 421, num. 2-3, p. 204-36, 2012.
. Semisynthesis and Total Chemical Synthesis of alpha-synuclein to study Post-Translational Modifications in Health and Disease. 22nd American Peptide Symposium, San Diego, CA, 2011.
Phosphorylation of alpha-Synuclein at Y125 and S129 Alters Its Metal Binding Properties: Implications for Understanding the Role of alpha-Synuclein in the Pathogenesis of Parkinson's Disease and Related Disorders, in Acs Chemical Neuroscience, vol. 2, num. 11, p. 667-675, 2011.
Identification and characterization of novel classes of macrophage migration inhibitory factor (MIF) inhibitors with distinct mechanisms of action, in The Journal of biological chemistry, vol. 285, num. 34, p. 26581-98, 2010.
An integrative in silico methodology for the identification of modulators of macrophage migration inhibitory factor (MIF) tautomerase activity, in Bioorganic & medicinal chemistry, vol. 18, num. 14, p. 5425-40, 2010.
A new class of isothiocyanate-based irreversible inhibitors of macrophage migration inhibitory factor, in Biochemistry, vol. 48, num. 41, p. 9858-70, 2009.
. Developing Novel Tools for Elucidating the Structure-Function Relationship of Macrophage Migration Inhibitory Factor. , 2008.
. Réception par des psychiatres d'un reportage télévisuel sur la folie . , 2007.